This inventor holds 2 USPTO granted patents. Top assignee: University of Alberta. Active years: 2011-2012.
Company Filing History:
Years Active: 2011-2012
Title: Nataraj Kav: Innovator in Recombinant Antibodies
Introduction
Nataraj Kav is a prominent inventor based in Edmonton, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant antibodies. With a total of 2 patents, his work focuses on innovative solutions for agricultural and medical applications.
Latest Patents
Nataraj Kav's latest patents include groundbreaking inventions directed towards recombinant antibodies that bind to specific antigens. These antibodies comprise a single chain variable fragment (scFv) and can target antigens such as SSPG1d, aspartyl protease, or whole mycelium. His inventions also encompass antibodies linked to anti-fungal polypeptides, along with nucleic acid sequences encoding these antibodies and expression vectors that incorporate them. Furthermore, his patents extend to transgenic plants, seeds, tissues, or cells transformed with these expression vectors. Methods for producing transgenic plants that exhibit resistance and for detecting biological samples utilizing these antibodies are also included, along with immunoassay kits for the same.
Career Highlights
Nataraj Kav is affiliated with the University of Alberta, where he continues to advance his research in biotechnology. His work has garnered attention for its potential applications in enhancing agricultural resilience and improving disease detection methods.
Collaborations
Some of Nataraj Kav's notable coworkers include William Yajima and Bo Yang, who contribute to his research endeavors and collaborative projects.
Conclusion
Nataraj Kav's innovative work in recombinant antibodies positions him as a key figure in biotechnology. His patents reflect a commitment to advancing agricultural and medical technologies, showcasing the impact of his research on future developments.